Lipocine (NASDAQ:LPCN) Earns Hold Rating from Analysts at StockNews.com
Equities research analysts at StockNews.com started coverage on shares of Lipocine (NASDAQ:LPCN – Get Free Report) in a research report issued on Tuesday. The brokerage set a “hold” rating on the specialty pharmaceutical company’s stock. Lipocine Stock Performance Shares of NASDAQ:LPCN opened at $3.63 on Tuesday. The firm has a market cap of $19.42 million, […]
Equities research analysts at StockNews.com started coverage on shares of Lipocine (NASDAQ:LPCN – Get Free Report) in a research report issued on Tuesday. The brokerage set a “hold” rating on the specialty pharmaceutical company’s stock. Lipocine Stock Performance Shares of NASDAQ:LPCN opened at $3.63 on Tuesday. The firm has a market cap of $19.42 million, […]
